Literature DB >> 19605743

Dihydroorotate dehydrogenase polymorphism influences the toxicity of leflunomide treatment in patients with rheumatoid arthritis.

P Bohanec Grabar, B Rozman, D Logar, S Praprotnik, V Dolzan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19605743     DOI： 10.1136/ard.2008.099093

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  15 in total

1.  Clinical analysis of chinese patients with rheumatoid arthritis treated with leflunomide and methotrexate combined with different dosages of glucocorticoid.

Authors:  Cong-Zhu Ding; Yao Yao; Xue-Bing Feng; Yun Fang; Cheng Zhao; Yue Wang
Journal:  Curr Ther Res Clin Exp       Date:  2012-09

Review 2.  Pharmacogenetics: implications for therapy in rheumatic diseases.

Authors:  Lesley Davila; Prabha Ranganathan
Journal:  Nat Rev Rheumatol       Date:  2011-08-09       Impact factor: 20.543

3.  Inborn errors of pyrimidine metabolism: clinical update and therapy.

Authors:  Shanti Balasubramaniam; John A Duley; John Christodoulou
Journal:  J Inherit Metab Dis       Date:  2014-07-17       Impact factor: 4.982

4.  Genetic polymorphism of CYP1A2 but not total or free teriflunomide concentrations is associated with leflunomide cessation in rheumatoid arthritis.

Authors:  Ashley M Hopkins; Michael D Wiese; Susanna M Proudman; Catherine E O'Doherty; Richard N Upton; David J R Foster
Journal:  Br J Clin Pharmacol       Date:  2015-10-28       Impact factor: 4.335

5.  Pseudo-pseudo Meigs syndrome developed under the leflunomide therapy.

Authors:  Cemal Bes; Mehmet Soy
Journal:  Rheumatol Int       Date:  2009-10-21       Impact factor: 2.631

6.  Polymorphisms in cytochrome P450 2C19 enzyme and cessation of leflunomide in patients with rheumatoid arthritis.

Authors:  Michael D Wiese; Matthew Schnabl; Catherine O'Doherty; Llewellyn D Spargo; Michael J Sorich; Leslie G Cleland; Susanna M Proudman
Journal:  Arthritis Res Ther       Date:  2012-07-12       Impact factor: 5.156

7.  Lack of association between CAG repeat polymorphism in the androgen receptor gene and the outcome of rheumatoid arthritis treatment with leflunomide.

Authors:  Violetta Dziedziejko; Mateusz Kurzawski; Krzysztof Safranow; Andrzej Ossowski; Jaroslaw Piatek; Miroslaw Parafiniuk; Dariusz Chlubek; Andrzej Pawlik
Journal:  Eur J Clin Pharmacol       Date:  2011-10-14       Impact factor: 2.953

Review 8.  Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome and the Rheumatologist.

Authors:  Marwan H Adwan
Journal:  Curr Rheumatol Rep       Date:  2017-01       Impact factor: 4.686

9.  Leflunomide Suppresses the Growth of LKB1-Inactivated Tumors in the Immune-Competent Host and Attenuates Distant Cancer Metastasis.

Authors:  Rui Jin; Boxuan Liu; Xiuju Liu; Yijian Fan; Wei Peng; Chunzi Huang; Adam Marcus; Gabriel Sica; Melissa Gilbert-Ross; Yuan Liu; Wei Zhou
Journal:  Mol Cancer Ther       Date:  2020-12-08       Impact factor: 6.009

10.  Exome sequencing identifies the cause of a mendelian disorder.

Authors:  Sarah B Ng; Kati J Buckingham; Choli Lee; Abigail W Bigham; Holly K Tabor; Karin M Dent; Chad D Huff; Paul T Shannon; Ethylin Wang Jabs; Deborah A Nickerson; Jay Shendure; Michael J Bamshad
Journal:  Nat Genet       Date:  2009-11-13       Impact factor: 38.330
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.